Medline ® Abstract for Reference 24
of 'Toxicities associated with checkpoint inhibitor immunotherapy'
Hodi FS, Lee SJ, McDermott DF, et al. Multicenter, randomized phase II trial of GM-CSF (GM) plus ipilimumab (Ipi) versus Ipi alone in metastatic melanoma: E1608. J Clin Oncol 2013; 31:18s (abstract CRA9007).
no abstract available